February 28 &

RIFAXIMIN

List of brands containing rifaximin   

This page contains list of brands of authorized pharmaceutical specialties of the active principle rifaximin in the countries listed below:

Australia] [ Brazil] [ Canada] [ France] [ Germany] [ India] [ Italy] [ Japan] [ Mexico] [ Pakistan] [ Puerto Rico] [ Spain] [ Turkey] [ United Kingdom] [ U.S.A]

Given the nature of the pharmaceutical market, some specialties may be unavailable, have been removed from the pharmaceutical market or have changed its name. So that, in no case can take decisions based on the information contained in the page. MEDIZZINE is not responsible for any damage arising from the information provided, which may be incomplete or outdated.

Indications and usage     

Rifaximin is a bactericidal antibiotic which acts on microorganisms of the digestive system, in particular, gastrointestinal infections characterized by the resistance to other antimicrobial treatments.

Rifaximin, is indicated in resistant bacterial enterocolitis to symptomatic treatment in patients at risk for associated diseases, immunosuppression or older. Pseudomembranous colitis in vancomycin-resistant patients, acute diverticulitis. It is also indicated as pre and postoperative prophylaxis in surgery of the gastrointestinal tract, and as adjunctive therapy in hyperammonemia (an excessive increase of ammonia concentration in the blood).

Medizzine recommends consulting your doctor if you are unsure (or you do not know) why you have been given rifaximin.

Other ingredients of available commercial presentations:

Besides rifaximin, tablets contain sodium carboxymethyl starch, glycerol palmitostearate, precipitated silica, talcum, cellulose microgranulated, hydroxypropyl methylcellulose, titanium dioxide, disodium edetate, Propylene Glycol, iron oxide red.

Warning:

The composition of the various presentations may vary from one country to another. We recommend you consult the information provided by your local supplier.

Important information     

During prolonged treatment at elevated doses, or in the case of intestinal injury, a slight absorption of the drug may occur, which could cause a reddish discoloration of urine, a fact that has no significant importance.

Before taking the drug     

Do not use rifaximin

If you are allergic (hypersensitive) to rifaximin, or any of the other ingredients of the medicinal product prescribed to you. If you think may be allergic, ask your doctor.

Allergy symptoms may include:

- Asthma attacks with shortness of breath, audible wheezing or rapid breathing.
- More or less sudden swelling of the face, lips, tongue or elsewhere in the body. It is especially critical if it affects the vocal cords.
- Hives, itching, rash
- Anaphylactic shock (loss of consciousness, paleness, sweating, etc.).

Nor you should take this medicine:

If you suffer from intestinal obstruction, even partial, and intestinal ulcerative lesions.

Take special care with rifaximin

Since rifaximin has virtually no gastrointestinal absorption, no special precautions are required for oral administration.

Remember that your doctor has prescribed this medicine only for you. Never give it to someone else.

If in doubt, consult your doctor.

Taking other medicines

Tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including herbal products or drugs obtained without a prescription.

It may be necessary to change the dose, or in some cases, discontinue one treatment. This applies to all types of drugs, but especially for:

Due also to its negligible absorption, it is unlikely any general type of drug interaction with other medications.

There is a possibility that rifaximin can interact with other medicines, such as cyclosporine, oral contraceptives, and warfarin.

Use with food and beverages

rifaximin may be taken before, during or after meals

Special physiological situations

Pregnancy and lactation:

Always consult your doctor or pharmacist before taking any medicine during pregnancy or breastfeeding.

Before starting treatment with rifaximin, you must inform the doctor if you are pregnant or are breastfeeding. Although not proven its possible action on the fetus, and given that many drugs are excreted in breast milk, its administration is recommended with caution during pregnancy and lactation.

Children and the elderly:

Although Rifaximin is a nonabsorbable antibiotic, it is recommended use with caution and under medical direct control in these particular cases.

Driving and using machines

There have been observed no alterations in the ability for driving or operating machinery while being treated with rifaximin.

Consult your doctor or pharmacist before taking any medicine.

How to use rifaximin     

Follow carefully instructions of use of rifaximin provided by your doctor. Consult your doctor or pharmacist when in doubt. Follow the instructions of the physician in preference to those given in this website, which may be different. Ask your doctor to explain any aspect that you do not understand, contained in the instruction leaflet that comes with the medicine.

Rifaximin is administered orally. The recommended adult dose is 200 mg (1 tablet or 10 ml suspension) every 6 hours, until remission of symptoms. This dose may be increased to 400 mg every 8 hours in adults in cases which may require an increase in the doses due to its complications, always under physician surveillance. It is advised not to exceed 7 days of treatment.

If you think the effect of the medicine is too strong or too weak, consult your doctor.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

While you take rifaximin     

If a doctor prescribes another medicine, tell you are taking rifaximin.

Check with your doctor regularly developments of disorder that motivates the use of rifaximin. Maybe there is some reason that prevented you properly receive the indicated doses and induce your doctor to erroneous conclusions about treatment.

Do not restart treatment with rifaximin at your own risk without first talking to your doctor, nor encourage its use by another person, even if have the same symptoms you have. Nor is it advisable to interrupt or reduce the dose without considering the opinion of your doctor.

If you feel unwell during treatment with rifaximin, immediately consult your doctor.

If you take more than you should:

In the case of overdose or accidental ingestion, consult the Toxicology Information Service in your country.

The treatment in these cases consists of gastric lavage and later administration of symptomatic treatment.

If you forget to take rifaximin

Take your dose as soon as you remember. Continue your treatment as usual. Do not take a double dose to make up for forgotten individual doses.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

Side Effects of rifaximin     

Like all medicines, rifaximin can cause side effects although not everybody gets them.

The frequency of side effects is classified into:

Rarely have been described, in some isolated cases, allergic reactions by individual hypersensitivity to rifaximin, manifested as skin reaction in the form of itching and reddening of the skin. In some cases, it is also described the appearance of nausea after drug administration, which disappears spontaneously without the treatment discontinuation.

This list does not include all adverse reactions associated with the use of rifaximin, both well established as those that are under consideration or confirmation. In case you feel unwell, should immediately consult with the doctor who prescribed this medicine.

If you notice any side effects not listed in this website or in the leaflet accompanying the package, ask your doctor or pharmacist.

If any of the side effects gets serious, tell your doctor or pharmacist.

List of brands containing rifaximin     

This page contains list of brands of authorized pharmaceutical specialties of the active principle rifaximin in the countries listed below:

Australia] [ Brazil] [ Canada] [ France] [ Germany] [ India] [ Italy] [ Japan] [ Mexico] [ Pakistan] [ Puerto Rico] [ Spain] [ Turkey] [ United Kingdom] [ U.S.A]

Given the nature of the pharmaceutical market, some specialties may be unavailable, have been removed from the pharmaceutical market or have changed its name. So that, in no case can take decisions based on the information contained in the page. MEDIZZINE is not responsible for any damage arising from the information provided, which may be incomplete or outdated.

Warning:

With exceptions expressly indicated, these lists do not include active principle associations with other drugs or clinical use containers.

Australia:     

XIFAXAN 200 mg, tablets

Brazil:     

N/A

Canada:     

ZAxINE 550 mg, 60 tablets

France:     

N/A

Germany:     

RIFAX AW 200 mg, tablets
RIFAXAN AW 200 mg, tablets
TiIXTELLER 550 mg, tablets
XIFAXAN 200 mg, tablets
XIFAXAN 550 mg, tablets

India:     

RCIFAX 200 mg, tablets
REFATIME 200 mg, tablets
RFX 200 mg, tablets
RIFAGUT 200 mg, tablets
RIFAGUT 400 mg, tablets
RIXMIN 400 mg, tablets
SIBOFIX 200 mg, tablets
SIBOFIX 400 mg, tablets
TORFIX 200 mg, tablets

Italy:     

NORMIX 200 mg, 12 tablets
NORMIX 2g/100 ml, granules for 60 ml oral suspension
RIFACOL 200 mg 12 tablets
RIFACOL 2g/100 ml, granules for 60 ml oral suspension

Japan:     

N/A

Mexico:     

FLONORM 100 mg/5 ml, 60 ml oral suspension
FLONORM 200 mg, 12 & 28 dragees

Pakistan:     

HIDROFAX 200 mg, tablets
NIMIXA 200 mg, tablets
NIMIXA 550 mg, tablets
NIXAT 200 mg, tablets
NIXAT 550 mg, tablets
RIFAXA 200 mg, tablets
RIFAXA 550 mg, tablets

Spain:     

SPIRAXIN 200 mg, 12 tablets

Turkey:     

COLIDUR 200 mg, 12 tablets NORMIX 200 mg, 12 tablets

United Kingdom:     

TARGAXAN 550 mg, 56 tablets
XIFAXANTA 200mg tablets

U.S.A. and Puerto Rico:     

XIFAXAN 200 mg, 3, 9, 30 & 100 tablets
XIFAXAN 550 mg, 2, 6, 9, 10 & 60 tablets

Page updated: December 11, 2010.